Quantifying the contribution of alcohol to cardiomyopathy: A systematic review.
Sign Up to like & getrecommendations! Published in 2017 at "Alcohol"
DOI: 10.1016/j.alcohol.2017.01.011
Abstract: Alcohol has a direct toxic impact on the heart, and while there is an ICD code for alcoholic cardiomyopathy, the burden of alcohol-attributable cardiomyopathy is not clear. For the usual estimation of this burden via… read more here.
Keywords: quantifying contribution; contribution alcohol; cardiomyopathy systematic; alcohol cardiomyopathy ... See more keywords
Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.13593
Abstract: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac condition and the most common cause of sudden cardiac death (SCD) in patients below the age of 35. Genetic testing is a vital part of HCM… read more here.
Keywords: genotypes hypertrophic; cardiomyopathy systematic; clinical prediction; systematic review ... See more keywords
COVID-19 and Cardiomyopathy: A Systematic Review
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.695206
Abstract: Background: Cardiomyopathies (CMPs) due to myocytes involvement are among the leading causes of sudden adolescent death and heart failure. During the COVID-19 pandemic, there are limited data available on cardiac complications in patients with COVID-19,… read more here.
Keywords: medicine; cardiomyopathy systematic; covid cardiomyopathy; systematic review ... See more keywords
Metalloproteinases and Hypertrophic Cardiomyopathy: A Systematic Review
Sign Up to like & getrecommendations! Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13040665
Abstract: Hypertrophic cardiomyopathy (HCM) is a genetic condition determined by an altered collagen turnover of the extracellular matrix. Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are abnormally released in patients with HCM. The purpose of this… read more here.
Keywords: cardiomyopathy systematic; hypertrophic cardiomyopathy; metalloproteinases hypertrophic; systematic review ... See more keywords